vimarsana.com

Page 5 - மருத்துவ ஆராய்ச்சி ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NA Proactive news snapshot: PlantX Life Inc, 1933 Industries Inc, Dyadic International, Inc, Klondike Gold Corp, CleanSpark Inc, IEC Electronics Corp, MGX Minerals Inc, Victory Resources Corporation, Real Luck Group Ltd, Namaste Technologies Inc, Fireweed

NA Proactive news snapshot: PlantX Life Inc, 1933 Industries Inc, Dyadic International, Inc, Klondike Gold Corp, CleanSpark Inc, IEC Electronics Corp, MGX Minerals Inc, Victory Resources Corporation, Real Luck Group Ltd, Namaste Technologies Inc, Fireweed
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr KSS MD, PhD

Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr. KSS MD, PhD Algernon Pharmaceuticals Inc.  a clinical stage pharmaceutical development company, is pleased to announce that Algernon’s CEO Christopher J. Moreau and CSO Dr. Mark Williams, will be discussing the Company’s New DMT Stroke Clinical Research Program on an upcoming BioPub webcast. The webcast will be held Wednesday February 3, 2021 hosted by Dr. KSS at Noon EST. The Company invites interested shareholders, … Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that Algernon’s CEO Christopher J. Moreau and CSO Dr. Mark Williams, will be discussing the Company’s New DMT Stroke Clinical Research Program on an upcoming BioPub webcast.

Researchers develop patient-informed questionnaire tool for ventral hernia repair surgery patients

Researchers develop patient-informed questionnaire tool for ventral hernia repair surgery patients Patient-reported outcomes have become a critical part of improving surgical care because of their ability to capture patient experiences, such as quality of life and satisfaction, that can help inform treatment. However, for patients undergoing abdominal hernia repair a common procedure performed on about 400,000 patients a year in the United States a tool to effectively and practically measure those outcomes has not been widely accepted and implemented by clinics. Now, researchers from the division of Plastic Surgery in the department of Surgery in the Perelman School of Medicine at the University of Pennsylvania, have successfully developed, tested, and implemented a first-of-its-kind, patient-informed questionnaire tool for ventral hernia repair surgery patients that could be broadly used to improve the way clinicians care for patients and potentially outcomes.

Lessons From The First Global Health Crisis: The Clint Spencer Clinic And The Fight Against HIV

Lessons From The First Global Health Crisis: The Clint Spencer Clinic And The Fight Against HIV
wrcbtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wrcbtv.com Daily Mail and Mail on Sunday newspapers.

Algernon Pharmaceuticals Provides Year End Summary of Key Activities

Algernon Pharmaceuticals Provides Year End Summary of Key Activities Algernon Pharmaceuticals Inc.  a clinical stage pharmaceutical development company, is pleased to provide a summary of the Company’s key activities this past calendar year. NP-120 Idiopathic Pulmonary Fibrosis & Chronic Cough Clinical Research Program March 30 – Submitted for ethics approval in Australia for a Phase 2 study of the Company’s re-purposed drug Ifenprodil for IPF and chronic cough. May 6 – … Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to provide a summary of the Company’s key activities this past calendar year.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.